Medgend Icon

Ledgend of Medicine







discontinued


Rasuvo FDA Approved Drugs

OTREXUP [MethotrexateC20H22N8O5]
RX
-
10mg/0.4ml (10mg/0.4ml) (subcutaneous solution)
12.5mg/0.4ml (12.5mg/0.4ml) (subcutaneous solution)
15mg/0.4ml (15mg/0.4ml) (subcutaneous solution)
17.5mg/0.4ml (17.5mg/0.4ml) (subcutaneous solution)
20mg/0.4ml (20mg/0.4ml) (subcutaneous solution)
22.5mg/0.4ml (22.5mg/0.4ml) (subcutaneous solution)
25mg/0.4ml (25mg/0.4ml) (subcutaneous solution)
Antares Pharma IncOct 11, 2013
  • Subcutaneous injection of methotrexate.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

RASUVO [MethotrexateC20H22N8O5]
RX
-
10mg/0.20ml (10mg/0.20ml) (subcutaneous solution)
12.5mg/0.25ml (12.5mg/0.25ml) (subcutaneous solution)
15mg/0.30ml (15mg/0.30ml) (subcutaneous solution)
17.5mg/0.35ml (17.5mg/0.35ml) (subcutaneous solution)
20mg/0.4ml (20mg/0.4ml) (subcutaneous solution)
22.5mg/0.45ml (22.5mg/0.45ml) (subcutaneous solution)
25mg/0.5ml (25mg/0.5ml) (subcutaneous solution)
30mg/0.6ml (30mg/0.6ml) (subcutaneous solution)
7.5mg/0.15ml (7.5mg/0.15ml) (subcutaneous solution)
Medac Pharma IncJul 10, 2014
  • Subcutaneous injection of methotrexate.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.